Skip to main navigation Skip to search Skip to main content

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

  • Santini Daniele
  • , Barni Sandro
  • , Intagliata Salvatore
  • , Falcone Alfredo
  • , Ferraù Francesco
  • , Galetta Domenico
  • , Moscetti Luca
  • , La Verde Nicla
  • , Ibrahim Toni
  • , Petrelli Fausto
  • , Vasile Enrico
  • , Ginocchi Laura
  • , Ottaviani Davide
  • , Longo Flavia
  • , Ortega Cinzia
  • , Russo Antonio
  • , Badalamenti Giuseppe
  • , Collovà Elena
  • , Lanzetta Gaetano
  • , Mansueto Giovanni
  • Adamo Vincenzo, De Marinis Filippo, Satolli Maria Antonietta, Cantile Flavia, Mancuso Andrea, Francesca Maria Tanca, Addeo Raffaele, Russano Marco, M. Sterpi, Pantano Francesco, Vincenzi Bruno, Tonini Giuseppe

Research output: Contribution to journal › Article › peer-review

Abstract

We conducted a large, multicenter, retrospective survey aimed to explore the impact of tumor bone involvement in Non-Small Cell Lung Cancer.Data on clinical-pathology, skeletal outcomes and bone-directed therapies for 661 deceased patients with evidence of bone metastasis were collected and statistically analyzed. Bone metastases were evident at diagnosis in 57.5% of patients. In the remaining cases median time to bone metastases appearance was 9 months. Biphosphonates were administered in 59.6% of patients. Skeletal-related events were experienced by 57.7% of patients; the most common was the need for radiotherapy. Median time to first skeletal-related event was 6 months. Median survival after bone metastases diagnosis was 9.5 months and after the first skeletal-related event was 7 months. We created a score based on four factors used to predict the overall survival from the diagnosis of bone metastases: age >65 years, non-adenocarcinoma histology, ECOG Performance Status >2, concomitant presence of visceral metastases at the bone metastases diagnosis. The presence of more than two of these factors is associated with a worse prognosis.This study demonstrates that patients affected by Non-Small Cell Lung Cancer with bone metastases represent a heterogeneous population in terms of risk of skeletal events and survival.

Original languageEnglish (US)
Article number18670
JournalScientific reports
Volume5
DOIs
StatePublished - Dec 22 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Natural History of Non-Small-Cell Lung Cancer with Bone Metastases'. Together they form a unique fingerprint.

Cite this